Sandra Orsulic, PhD
Director, Women's Cancer Biology
|Link to the research lab|
Sandra Orsulic, PhD is Director of Women's Cancer Biology at the Women's Cancer Program at Cedars-Sinai Medical Center. Her primary research interests include mouse models of ovarian carcinoma, the molecular characterization of ovarian cancer, and pathway-targeted therapy.
Prior to joining Cedars-Sinai, Dr. Orsulic was Principal Investigator of a research laboratory at the Massachusetts General Hospital in Boston, where she also served as Assistant Professor of Pathology at Harvard Medical School.
Dr. Orsulic is a member of the National Cancer Institute's Mouse Models of Human Cancers Consortium Steering Committee and Chair of the Gynecological Cancers Working Group. She is also a member of The Cancer Genome Atlas Project Ovarian Carcinoma Working Group, which investigates the underlying genetic changes that occur in human ovarian cancer.
Dr. Orsulic's research on ovarian cancer has been funded by the National Institutes of Health, Department of Defense, American Cancer Society, Ovarian Cancer Research Fund, and the Susan G. Komen Foundation. Her work has been published in numerous peer-reviewed journals, such as Nature, Cancer Cell, The Journal of Cell Biology, Cancer Research, Development, and Proceedings of the National Academy of Sciences, USA.
Dr. Orsulic earned her bachelor's degree from the University of Zagreb, Croatia and her doctorate from the University of North Carolina at Chapel Hill. She was a postdoctoral fellow in the laboratory of Nobel Prize Laureate Dr. Harold Varmus at the National Institutes of Health and Memorial Sloan-Kettering Cancer Center.